FERRARO, Donatella
FERRARO, Donatella
Promozione della Salute, Materno-Infantile, di Medicina Interna e Specialistica di Eccellenza “G. D’Alessandro”
A rs4374383 Single Nucleotide Polymorphisms of MERTK gene is linked to a higher likelihood of hepatocellular carcinoma in patients with HCV cirrhosis
2013-01-01 DI MARCO, V.; Calvaruso, V.; Grimaudo, S.; Ferraro, D.; Bavetta, M.; Di Cristina, A.; Cabibbo, G.; Conte, E.; Craxi, A.
Age and Cytokine Gene Variants Modulate the Immunogenicity and Protective Effect of SARS-CoV-2 mRNA-Based Vaccination
2023-02-10 Scola L.; Ferraro D.; Sanfilippo G.L.; De Grazia S.; Lio D.; Giammanco G.M.
An Analysis of the Neutralizing Antibodies against the Main SARS-CoV-2 Variants in Healthcare Workers (HCWs) Vaccinated against or Infected by SARS-CoV-2
2023-11-08 Immordino P.; Pisciotta V.; Amodio E.; Bonura C.; Bonura F.; Cacioppo F.; Calamusa G.; Capra G.; Casuccio A.; De Grazia S.; Genovese D.; Graci D.; Lacca G.; Sanfilippo G.L.; Verso M.G.; Giammanco G.M.; Ferraro D.
Anti-hepatitis A virus seroprevalence and seroconversion in a cohort of patients with chronic viral hepatitis
2002-01-01 Stroffolini, T.; Almasio, P.; DI STEFANO, R.; Andreone, P.; Di Gaetano, G.; Fattovich, G.; Gaeta, G.; Morisco, F.; Smedile, A.; Tripi, S.; Zignego, A.; Ferraro, D.; Mele, A.; Craxi, A.
Antibodies Responses to SARS-CoV-2 in a Large Cohort of Vaccinated Subjects and Seropositive Patients
2021-07-01 Amodio, Emanuele; Capra, Giuseppina; Casuccio, Alessandra; Grazia, Simona De; Genovese, Dario; Pizzo, Stefano; Calamusa, Giuseppe; Ferraro, Donatella; Giammanco, Giovanni Maurizio; Vitale, Francesco; Bonura, Floriana
Assessment of hepatitis C virus-RNA clearance under combination therapy for hepatitis C virus genotype 1: performance of transcription-mediated amplification assay
2008-01-01 FERRARO D; M GIGLIO; C BONURA; V DI MARCO; MU MONDELLI; A CRAXì; R DI STEFANO
Atypical case of monkeypox with multiple bacterial skin superinfection
2023-05-09 Pipito' L.; Mancuso A.; Zichichi F.; Ferraro D.; Giammanco G.M.; Cascio A.
Bayesian coalescent inference of hepatitis C virus introduction from molecular sequences: the Camporeale model
2006-01-01 ANGELIN C; GENOVESE D; FERRARO D; GIORDANO V; GIGLIO M; TAFFON S; CRAX A; STROFFOLINI T; DI STEFANO R; RAPICETTA M
Binding of flunitrazepam to differentiating neurons cultured in a chemically defined, hormone-supplemented medium
1990-01-01 Savettieri, G.; Guarneri, R.; Salemi, G.; LA BELLA, V.; Ferraro, D.; Scondotto, S.; Piccoli, F.
Characterization of measles virus strains circulating in Southern Italy (Palermo area, Sicily) between 2010 and 2011
2016-01-01 Urone, N.; Colomba, C.; Ferraro, D.
Cinetica della risposta virologica e della comparsa di mutanti virali in pazienti con malattia cronica di fegato HBV-correlatain terapia con adefovir
2005-01-01 CARDINALE F; FERRARO D; GIGLIO M; PIZZILLO P; DI MARCO V; CRAXI'A; DI STEFANO R
Different doses of consensus interferon plus ribavirin in patients with hepatitis C virus genotype 1 relapsed after interferon monotherapy: a randomized controlled trial
2006-01-01 Alaimo, G.; DI MARCO, V.; Ferraro, D.; DI STEFANO, R.; Porrovecchio, S.; D'Angelo, F.; Calvaruso, V.; Craxi, A.; Almasio, P.
Differing kinetics of anti-spike protein IgGs and neutralizing antibodies against SARS-CoV-2 after Comirnaty (BNT162b2) immunization
2022-01-26 Bonura, Floriana; De Grazia, Simona; Bonura, Celestino; Sanfilippo, Giuseppa L; Giammanco, Giovanni; Amodio, Emanuele; Ferraro, Donatella
Do not forget mpox!
2024-05-31 Pipito' L.; Trizzino M.; Ferraro D.; Cala' C.; Giammanco G.; Cascio A.
Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction
2002-01-01 DI MARCO, V.; Ferraro, D.; Almasio, P.; Vaccaro, A.; Parisi, P.; Cappello, M.; Cino, N.; DI STEFANO, R.; Craxi, A.
Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension
2016-01-01 Di Marco, V.; Calvaruso, V.; Ferraro, D.; Bavetta, M.; Cabibbo, G.; Conte, E.; Cammà, C.; Grimaudo, S.; Pipitone, R.; Simone, F.; Peralta, S.; Arini, A.; Craxì, A.
Efficacy of 8 weeks elbasvir/grazoprevir regimen for naïve-genotype 1b, HCV infected patients with or without glucose abnormalities: Results of the EGG18 study
2021-01-01 Vincenza Calvaruso , Salvatore Petta, Donatella Ferraro, Claudia La Mantia, Gerlando Gibilaro, Giada Reina, Velia Chiara Di Maio, Anna Licata, Francesca Ceccherini-Silberstein, Vito Di Marco, Antonio Craxì
Endemic hepatitis C virus infection in a Sicilian town: Further evidence for iatrogenic transmission
2002-01-01 DI STEFANO, R.; Stroffolini, T.; Ferraro, D.; Usticano, A.; Valenza, L.; Montalbano, L.; Pomara, G.; Craxi, A.
Epidemiologia molecolare dell'infezione da HCV in un Comune Siciliano
2005-01-01 FERRARO D; GIORDANO V; GIGLIO M; ARGENTINI C; GENOVESE D; STROFFOLINI T; RAPICETTA M; CRAXI' A; DI STEFANO R
EVALUATING THE RISK OF HEPATITIS B REACTIVATION IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES: IS THE SERUM HEPATITIS B PROFILE RELIABLE?
2009-01-01 FERRARO, D; PIZZILLO, P; DI MARCO, V; VULTAGGIO, A; IANNITTO, E; VENEZIA, G; CRAXì, A; DI STEFANO, R